Lance R Peterson1, Susan Boehm2, Jennifer L Beaumont3, Parul A Patel2, Donna M Schora2, Kari E Peterson2, Deborah Burdsall4, Carolyn Hines5, Maureen Fausone2, Ari Robicsek6, Becky A Smith6. 1. Department of Medicine, University of Chicago Pritzker School of Medicine, Chicago, IL; Department of Pathology, University of Chicago Pritzker School of Medicine, Chicago, IL; Division of Infectious Diseases, Department of Medicine, NorthShore University HealthSystem, Evanston, IL; Division of Microbiology, Department of Pathology and Laboratory Medicine, NorthShore University HealthSystem, Evanston, IL; Department of Infection Control, NorthShore University HealthSystem, Evanston, IL. Electronic address: lance1@uchicago.edu. 2. Division of Microbiology, Department of Pathology and Laboratory Medicine, NorthShore University HealthSystem, Evanston, IL. 3. Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL. 4. Lutheran Life Communities, Arlington Heights, IL. 5. Department of Infection Control, NorthShore University HealthSystem, Evanston, IL. 6. Department of Medicine, University of Chicago Pritzker School of Medicine, Chicago, IL; Division of Infectious Diseases, Department of Medicine, NorthShore University HealthSystem, Evanston, IL; Department of Infection Control, NorthShore University HealthSystem, Evanston, IL.
Abstract
BACKGROUND:Antibiotic resistance is a challenge in long-term care facilities (LTCFs). The objective of this study was to demonstrate that a novel, minimally invasive program not interfering with activities of daily living or socialization could lower methicillin-resistant Staphylococcus aureus (MRSA) disease. METHODS: This was a prospective, cluster-randomized, nonblinded trial initiated at 3 LTCFs. During year 1, units were stratified by type of care and randomized to intervention or control. In year 2, all units were converted to intervention consisting of universal decolonization using intranasal mupirocin and a chlorhexidine bath performed twice (2 decolonization-bathing cycles 1 month apart) at the start of the intervention period. Subsequently, after initial decolonization, all admissions were screened on site using real-time polymerase chain reaction, and those MRSA positive were decolonized, but not isolated. Units received annual instruction on hand hygiene. Enhanced bleach wipe cleaning of flat surfaces was done every 4 months. RESULTS: There were 16,773 tests performed. The MRSA infection rate decreased 65% between baseline (44 infections during 365,809 patient days) and year 2 (12 infections during 287,847 patient days; P <.001); a significant reduction was observed at each of the LTCFs (P <.03). CONCLUSIONS: On-site MRSA surveillance with targeted decolonization resulted in a significant decrease in clinical MRSA infection among LTCF residents. Copyright Â
RCT Entities:
BACKGROUND: Antibiotic resistance is a challenge in long-term care facilities (LTCFs). The objective of this study was to demonstrate that a novel, minimally invasive program not interfering with activities of daily living or socialization could lower methicillin-resistant Staphylococcus aureus (MRSA) disease. METHODS: This was a prospective, cluster-randomized, nonblinded trial initiated at 3 LTCFs. During year 1, units were stratified by type of care and randomized to intervention or control. In year 2, all units were converted to intervention consisting of universal decolonization using intranasal mupirocin and a chlorhexidine bath performed twice (2 decolonization-bathing cycles 1 month apart) at the start of the intervention period. Subsequently, after initial decolonization, all admissions were screened on site using real-time polymerase chain reaction, and those MRSA positive were decolonized, but not isolated. Units received annual instruction on hand hygiene. Enhanced bleach wipe cleaning of flat surfaces was done every 4 months. RESULTS: There were 16,773 tests performed. The MRSA infection rate decreased 65% between baseline (44 infections during 365,809 patient days) and year 2 (12 infections during 287,847 patient days; P <.001); a significant reduction was observed at each of the LTCFs (P <.03). CONCLUSIONS: On-site MRSA surveillance with targeted decolonization resulted in a significant decrease in clinical MRSA infection among LTCF residents. Copyright Â
Authors: Donna M Schora; Susan Boehm; Sanchita Das; Parul A Patel; Jennifer O'Brien; Carolyn Hines; Deborah Burdsall; Jennifer Beaumont; Kari Peterson; Maureen Fausone; Lance R Peterson Journal: Am J Infect Control Date: 2014-10 Impact factor: 2.918
Authors: Rajiv Jain; Stephen M Kralovic; Martin E Evans; Meredith Ambrose; Loretta A Simbartl; D Scott Obrosky; Marta L Render; Ron W Freyberg; John A Jernigan; Robert R Muder; LaToya J Miller; Gary A Roselle Journal: N Engl J Med Date: 2011-04-14 Impact factor: 91.245
Authors: F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan Journal: J Clin Microbiol Date: 1995-09 Impact factor: 5.948
Authors: Nimalie D Stone; Muhammad S Ashraf; Jennifer Calder; Christopher J Crnich; Kent Crossley; Paul J Drinka; Carolyn V Gould; Manisha Juthani-Mehta; Ebbing Lautenbach; Mark Loeb; Taranisia Maccannell; Preeti N Malani; Lona Mody; Joseph M Mylotte; Lindsay E Nicolle; Mary-Claire Roghmann; Steven J Schweon; Andrew E Simor; Philip W Smith; Kurt B Stevenson; Suzanne F Bradley Journal: Infect Control Hosp Epidemiol Date: 2012-10 Impact factor: 3.254
Authors: Linda K McDougal; Christine D Steward; George E Killgore; Jasmine M Chaitram; Sigrid K McAllister; Fred C Tenover Journal: J Clin Microbiol Date: 2003-11 Impact factor: 5.948
Authors: William A Bowler; Jeanine Bresnahan; Ann Bradfish; Christine Fernandez Journal: Infect Control Hosp Epidemiol Date: 2010-03 Impact factor: 3.254
Authors: Arthur Tang; Kin On On Kwok; Vivian Wan In Wan In Wei; Hong Chen; Samuel Yeung Shan Yeung Shan Wong; Wilson Wai Sun Wai Sun Tam Journal: Antibiotics (Basel) Date: 2021-02-24
Authors: Valerie Wing Yu Wong; Ying Huang; Wan In Wei; Samuel Yeung Shan Wong; Kin On Kwok Journal: Antimicrob Resist Infect Control Date: 2022-01-15 Impact factor: 4.887